|
|
Substance Name: O-Methylbufotenine
RN: 1019-45-0
UNII: X0MKX3GWU9
InChIKey: ZSTKHSQDNIGFLM-UHFFFAOYSA-N
Note
- Compounds that contain the biogenic monoamine tryptamine and are substituted with one methoxy group and two methyl groups. Members of this group include several potent serotonergic hallucinogens found in several unrelated plants, skins of certain toads, and in mammalian brains. They are possibly involved in the etiology of schizophrenia.
Molecular Formula
- C13-H18-N2-O
Molecular Weight
- 218.2982
Classification Code
- Natural Product
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Regulatory Agencies (Superlist Locators)
Other Resources (Internet Locators)
Search for this InChIKey on the Web
Names and Synonyms
Results Name
- O-Methylbufotenine
Name of Substance
- N,N-Dimethyl-5-methoxytryptamine
MeSH Heading
- Methoxydimethyltryptamines
Synonyms
- 3-(2-(N,N-Dimethyl)aminoethyl)-5-methoxyindole
- 3-(2-Dimethylaminoethyl)-5-methoxyindole
- 5-22-12-00027 (Beilstein Handbook Reference)
- 5-MeO-DMT
- 5-Methoxy-N,N-dimethyl-1H-indole-3-ethanamine
- 5-Methoxy-N,N-dimethyltryptamine
- 5-Methoxydimethyltryptamine
- BRN 0164771
- Bufotenine, O-methyl-
- CT 4334
- EINECS 213-813-2
- Indole, 3-(2-(dimethylamino)ethyl)-5-methoxy-
- Indole, 3-(2-(N,N-dimethylamino)ethyl)-5-methoxy-
- MeODMT
- Methoxybufotenin
- Methylbufotenine
- N,N-Dimethyl-5-methoxytryptamine
- NSC 88624
- O-Methylbufotenine
- UNII-X0MKX3GWU9
Systematic Names
- 1H-Indole-3-ethanamine, 5-methoxy-N,N-dimethyl- (9CI)
- 5-Methoxy-N,N-dimethyl-1H-indole-3-ethylamine
- Indole, 3-(2-(dimethylamino)ethyl)-5-methoxy- (8CI)
- Indole, 3-(2-(N,N-dimethylamino)ethyl)-5-methoxy-
Registry Numbers
CAS Registry Number
- 1019-45-0
FDA UNII
- X0MKX3GWU9
System Generated Number
- 0001019450
Structure Descriptors
InChI
InChI=1S/C13H18N2O/c1-15(2)7-6-10-9-14-13-5-4-11(16-3)8-12(10)13/h4-5,8-9,14H,6-7H2,1-3H3InChIKey
ZSTKHSQDNIGFLM-UHFFFAOYSA-NSmiles
COc1ccc2[nH]cc(CCN(C)Toxicity
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 115mg/kg (115mg/kg) | Psychopharmacologia Vol. 16, Pg. 385, 1970. | |
mouse | LDLo | subcutaneous | 75mg/kg (75mg/kg) | BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS" | Science. Vol. 156, Pg. 970, 1967. |